5 hours Citigroup Lowers Integra LifeSciences (NASDAQ:IART) Price Target to $16.00 MarketBeat
Citigroup lowered their price objective on shares of Integra LifeSciences from $20.00 to $16.00 and set a “sell” rating for the company in a research note on Tuesday.
Citigroup (C) · Nasdaq 100 · Science